- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The Board of Directors of Dhanuka Agritech Limited has considered and approved the financial results for the quarter and nine months ended December 31, 2024. Key highlights include total income of ₹45,228.53 Cr, driven by revenue from operations of ₹44,527.21 Cr, reflecting robust growth. The company reported a profit before tax of ₹6,807.67 Cr and a profit after tax of ₹5,504.47 Cr. Additionally, Dhanuka has acquired international rights to active ingredients Iprovalicarb and Triadimenol from Bayer AG, aiming to expand its market presence across multiple geographies.